The United States on Wednesday authorized Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for people ages 12 and older at risk of severe illness, the first oral...
A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received the first dose of AstraZeneca or...